Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
9.52M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$29.8M
-
Value change
-
-$4.11M
-
Put/Call ratio
-
0
-
Number of buys
-
21
-
Number of sells
-
-43
-
Price
-
$3.13
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q3 2024
89 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q3 2024.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.52M shares
of 17.3M outstanding shares and own 55.18% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.7M shares), Solas Capital Management, LLC (1.27M shares), VANGUARD GROUP INC (836K shares), Alta Fundamental Advisers LLC (720K shares), Prosight Management, LP (571K shares), Newtyn Management, LLC (570K shares), ACADIAN ASSET MANAGEMENT LLC (381K shares), RBF Capital, LLC (360K shares), BlackRock, Inc. (346K shares), and Verition Fund Management LLC (340K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.